J W Vardiman
About
In The Last Decade
J W Vardiman
16 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Hematology 1.5k
- Genetics 692
- Molecular Biology 558
- Public Health, Environmental and Occupational Health 415
- Oncology 271
Countries citing papers authored by J W Vardiman
This map shows the geographic impact of J W Vardiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J W Vardiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J W Vardiman more than expected).
Fields of papers citing papers by J W Vardiman
This network shows the impact of papers produced by J W Vardiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J W Vardiman. The network helps show where J W Vardiman may publish in the future.
Co-authorship network of co-authors of J W Vardiman
This figure shows the co-authorship network connecting the top 25 collaborators of J W Vardiman. A scholar is included among the top collaborators of J W Vardiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J W Vardiman. J W Vardiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 37 | |
| 3 | Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. | 470 |
| 4 | 216 | |
| 5 | 25 | |
| 6 | Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia. | 37 |
| 7 | Recurring diagnostic problems in the pathology of the myelodysplastic syndromes. | 29 |
| 8 | The relationship between secondary chromosomal abnormalities and blast transformation in chronic myelogenous leukemia. | 36 |
| 9 | 110 | |
| 10 | 22 | |
| 11 | The t(2;5)(p23;q35): a recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. | 143 |
| 12 | Chromosome abnormalities in B cell chronic lymphocytic leukemia and their clinical correlations. | 65 |
| 13 | Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia. | 6 |
| 14 | Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. breakdown → | 567 |
| 15 | 19 | |
| 16 | 88 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.